Motavizumab, CAS 677010-34-3

Product Description: Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Mejías A, et al. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25;4:109./[2]Huang K, et al. Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. J Virol. 2010 Aug;84(16):8132-40.

CAS Number: 677010-34-3

Molecular Weight: N/A

Compound Purity: 98.35

Research Area: Infection

Solubility: 10 mM in DMSO

Target: RSV

• Artikelnummer: MEXHY-P99209-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99209-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK